ClinicalTrials.gg
Status unknownNCT01461694Updated May 14, 2012

Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser

A Phase 2/3 interventional study of Intense Pulsed Light (IPL) and Alexandrite Laser in Hirsutism, sponsored by NHS Greater Glasgow and Clyde. Status unknown at 1 site in United Kingdom. Open to female participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-05-14.

Sponsored by NHS Greater Glasgow and Clyde · Phase 2/3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2012), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Phase 2/3
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
16 Years and older
Sex
Female
01

Study summary

The purpose of this study is to compare the efficacy of the IPL system 650advance handpiece with the alexandrite laser for the purposes of female facial hair reduction

Read the detailed description

This is a randomised (splitface)controlled trial, comparing the use of the Intense Pulsed Light (IPL) system 650 advance handpiece against the Alexandrite Laser for the purposes of female facial hair reduction. Previous studies have shown that the alexandrite laser is superior to IPL in achieving hair reduction. A new handpiece (Lynton, Lumina 650 advance) available for the IPL system is designed to further optimise its use in removing female facial hair (particularly those hair colours previously unresponsive to treatment). This study will compare the alexandrite laser to the IPL system using the new handpiece. This may lead to improvements in the treatment of female patients with male pattern facial hair. Female patients referred to our facial hair reduction service will be recruited to this study. 1/2 their face will be treated with IPL and 1/2 with alexandrite laser. Each participant will receive 6 full treatments at approximately 6 weekly intervals. Participants will be asked to fill in a satisfaction questionnaire and have clinical photographs taken pre treatment and at 1 and 3months post final treatment. All treatments will be carried out in our dedicated laser suite at Glasgow Royal Infirmary.

02

Conditions studied

  • Hirsutism

Browse trials for

Keywords

  • Hirsutism
  • Laser
  • Hair Reduction
  • IPL
  • Intense Pulsed Light
03

In context

Hirsutism

41 studies on the registry are indexed under Hirsutism; 8 are open to participants now.

This study's planned enrollment of 35 is below the median of 43 across 26 interventional studies indexed under Hirsutism.

Browse Hirsutism studies →

Lead sponsor

NHS Greater Glasgow and Clyde is the lead sponsor of 220 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female Patients
  • Minimum age 16years old
  • Fitzpatrick skin types I-III
  • Significant facial hair.

Exclusion criteria

Exclusion Criteria:

  • Fitzpatrick skin types IV-VI
  • Age less than 16years old
  • Males
  • No visible facial hair growth
  • Use of electrolysis or depilatory creams 6weeks prior to treatment
  • Active acnes
  • Current coldsore
  • Previous facial hair removal with laser or IPL in past 12 months
  • Sun tanned skin
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
35 participants (estimated)

Study arms

  • Active comparator
    IPL

    Half face treated with IPL

    Device: Intense Pulsed Light (IPL)

  • Active comparator
    Alexandrite Laser

    Half face treated with Alexandrite Laser

    Device: Alexandrite Laser

Interventions

  • DeviceIntense Pulsed Light (IPL)

    Half Face Treated with IPL

  • DeviceAlexandrite Laser

    Half face treated with Alexandrite Laser

06

What researchers measure

Primary outcomes

  1. Change in total Hair Count measurement at 1month post final treatment from baseline

    Pre Treatment hair count assessed using videomicroscopy as baseline. Post final treatment hair counts will be measured again at 1month to assess if there has been a reduction in total hair count from pre-treatment

    Time frame: Baseline and 1 month

  2. Change in total hair count at 3months post final treatment from baseline

    Pre Treatment hair count assessed using videomicroscopy as baseline. Post final treatment hair counts will be measured again at 3months to assess if there has been a reduction in total hair count from pre-treatment

    Time frame: Baseline and 3months post final treatment

07

Study locations

1 site
  • Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary
    Glasgow, G4 0SF, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01461694
Responsible party
Adam Gilmour (Clinical Laser Research Fellow, NHS Greater Glasgow and Clyde) — Principal investigator
First posted
Oct 28, 2011
Start date
Nov 2011
Primary completion
Mar 2013 (estimated)
Completion
Mar 2013 (estimated)
Last update
May 14, 2012

Study contacts

Adam Gilmour, MBChB, MRCS (Ed)
principal investigator · NHS Greater Glasgow & Clyde
Iain Mackay, MBChb, MRCS, FRCS (plast)
study chair · NHS Greater Glasgow & Clyde
Vivek Sivarajan, MBChB, MRCS, MD, FRCS (Plas)
study director · NHS Greater Glasgow & Clyde

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion